• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊维菌素在猪体内的分布及一些药代动力学参数。

The distribution and some pharmacokinetic parameters of ivermectin in pigs.

作者信息

Scott E W, McKellar Q A

机构信息

Department of Veterinary Pharmacology, University of Glasgow Veterinary School, Bearsden, UK.

出版信息

Vet Res Commun. 1992;16(2):139-46. doi: 10.1007/BF01839011.

DOI:10.1007/BF01839011
PMID:1496816
Abstract

Ivermectin was injected subcutaneously into five pigs at the usual dose rate of 300 micrograms/kg and found to distribute well to all tissues and body fluids which were sampled 24 h post-injection. Ivermectin was detected in the contents and mucus at all levels of the gastrointestinal tract. The drug was excreted in bile, with high concentrations of the drug in the intestines and faeces. High concentrations of ivermectin were measured in skin, ears and ear wax, suggesting that the drug should be effective in the treatment of ectoparasitic infestations, particularly ear mites. The high lipid solubility of the drug may explain the high concentrations found in ear wax and skin. Ivermectin was also detected in the body fluids and tissues of an untreated pig penned with the treated animals. Direct contact appeared to be necessary for transfer of ivermectin from the treated to the untreated pig but coprophagia or urine drinking is a possible explanation. The pharmacokinetics of ivermectin administered subcutaneously at a dose rate of 300 micrograms/kg to six pigs were studied. There was marked individual variation in the pharmacokinetics of ivermectin. In one pig the area under the plasma concentration-time curve was particularly high. This may reflect individual variation in uptake and excretion of the drug. The mean elimination half-life of the drug was 35.2 h, suggesting that the drug is cleared slowly from pigs with drug detectable in plasma for 6-10 days. This persistence should allow a short period of protection before re-infection with parasites.

摘要

以300微克/千克的常用剂量率将伊维菌素皮下注射到5头猪体内,发现其在注射后24小时分布到所有采样的组织和体液中。在胃肠道各部位的内容物和黏液中均检测到伊维菌素。该药物经胆汁排泄,在肠道和粪便中有高浓度的药物。在皮肤、耳朵和耳垢中检测到高浓度的伊维菌素,这表明该药物在治疗外寄生虫感染,特别是耳螨方面应该有效。药物的高脂溶性可能解释了在耳垢和皮肤中发现的高浓度。在与经治疗动物圈养在一起的一头未治疗猪的体液和组织中也检测到了伊维菌素。伊维菌素从经治疗猪转移到未治疗猪似乎需要直接接触,但食粪或饮尿也是一种可能的解释。研究了以300微克/千克的剂量率对6头猪皮下注射伊维菌素的药代动力学。伊维菌素的药代动力学存在明显的个体差异。在一头猪中,血浆浓度-时间曲线下面积特别高。这可能反映了药物吸收和排泄的个体差异。该药物的平均消除半衰期为35.2小时,这表明该药物在猪体内清除缓慢,血浆中药物可检测6至10天。这种持续性应能在再次感染寄生虫之前提供一段短暂的保护期。

相似文献

1
The distribution and some pharmacokinetic parameters of ivermectin in pigs.伊维菌素在猪体内的分布及一些药代动力学参数。
Vet Res Commun. 1992;16(2):139-46. doi: 10.1007/BF01839011.
2
Comparative distribution of ivermectin and doramectin to parasite location tissues in cattle.伊维菌素和多拉菌素在牛体内向寄生虫寄生组织的分布比较
Vet Parasitol. 2000 Feb 1;87(4):327-38. doi: 10.1016/s0304-4017(99)00175-2.
3
Clinical and pharmacological properties of ivermectin in rabbits and guinea pigs.伊维菌素在兔和豚鼠体内的临床及药理学特性
Vet Rec. 1992 Jan 25;130(4):71-3. doi: 10.1136/vr.130.4.71.
4
The effects of body composition on the pharmacokinetics of subcutaneously injected ivermectin and moxidectin in pigs.猪的体成分对皮下注射伊维菌素和莫西菌素药代动力学的影响。
J Vet Pharmacol Ther. 2002 Jun;25(3):227-32. doi: 10.1046/j.1365-2885.2002.00400.x.
5
Does the rate of fat deposition influence the pharmacokinetic disposition of subcutaneously administered moxidectin and ivermectin in pigs?
J Vet Pharmacol Ther. 2002 Oct;25(5):351-7. doi: 10.1046/j.1365-2885.2002.00435.x.
6
Breed differences in the pharmacokinetics of ivermectin administered subcutaneously to Holstein and Belgian Blue calves.皮下注射伊维菌素后荷斯坦犊牛和比利时蓝牛犊牛药代动力学的品种差异
Vet Parasitol. 2008 Mar 25;152(1-2):136-40. doi: 10.1016/j.vetpar.2007.11.021. Epub 2007 Dec 4.
7
Pharmacokinetics and bioequivalence in the pig of two ivermectin feed formulations.两种伊维菌素饲料制剂在猪体内的药代动力学及生物等效性
J Vet Pharmacol Ther. 2013 Aug;36(4):350-7. doi: 10.1111/j.1365-2885.2012.01428.x. Epub 2012 Aug 8.
8
Persistence of ivermectin in plasma and faeces following treatment of cows with ivermectin sustained-release, pour-on or injectable formulations.用伊维菌素缓释剂、浇泼剂或注射剂治疗奶牛后,伊维菌素在血浆和粪便中的残留情况。
Int J Parasitol. 1996 Oct;26(10):1087-93.
9
Effect of ivermectin on the control of ear mites (Psoroptes cuniculi) in naturally infested rabbits.伊维菌素对自然感染兔耳螨(兔痒螨)的控制效果。
Am J Vet Res. 1992 Jan;53(1):105-9.
10
Measurement of ivermectin concentrations in target worms and host gastrointestinal tissues: influence of the route of administration on the activity against resistant Haemonchus contortus in lambs.测定目标蠕虫和宿主胃肠道组织中的伊维菌素浓度:给药途径对抵抗性捻转血矛线虫活性的影响在羔羊。
Exp Parasitol. 2012 Jul;131(3):304-9. doi: 10.1016/j.exppara.2012.04.014. Epub 2012 May 7.

引用本文的文献

1
Does Ivermectin Pollute the Surroundings of Swine Farms?伊维菌素会污染养猪场周围环境吗?
Vet Med Sci. 2025 Nov;11(6):e70634. doi: 10.1002/vms3.70634.
2
Ivermectin toxicokinetics in rainbow trout (Oncorhynchus mykiss) following P-glycoprotein inhibition.经 P 糖蛋白抑制后,虹鳟鱼(Oncorhynchus mykiss)体内伊维菌素的毒代动力学。
Vet Res Commun. 2024 Oct;48(5):3139-3155. doi: 10.1007/s11259-024-10480-3. Epub 2024 Aug 6.
3
Pharmacokinetics of tenvermectin in swine, a novel antiparasitic drug candidate-comparison with ivermectin.

本文引用的文献

1
Pharmacokinetic studies of ivermectin: effects of formulation.伊维菌素的药代动力学研究:制剂的影响。
Vet Res Commun. 1985 Sep;9(4):251-68. doi: 10.1007/BF02215150.
2
Pharmacokinetics of ivermectin administered intravenously to cattle.
J Pharm Sci. 1985 Oct;74(10):1105-7. doi: 10.1002/jps.2600741020.
3
Normal phase liquid chromatographic determination of nanogram quantities of ivermectin in cattle blood or plasma.牛血或血浆中纳克级伊维菌素的正相液相色谱测定法。
J Assoc Off Anal Chem. 1985 Jan-Feb;68(1):36-40.
替米考星在猪体内的药代动力学研究——与伊维菌素的比较。
Vet Med Sci. 2023 May;9(3):1211-1216. doi: 10.1002/vms3.1085. Epub 2023 Feb 11.
4
Targeting cattle for malaria elimination: marked reduction of Anopheles arabiensis survival for over six months using a slow-release ivermectin implant formulation.针对疟疾消除目标:使用缓慢释放伊维菌素植入剂使阿拉伯按蚊的存活率显著降低六个月以上。
Parasit Vectors. 2018 May 4;11(1):287. doi: 10.1186/s13071-018-2872-y.
5
Cytochrome P450/ABC transporter inhibition simultaneously enhances ivermectin pharmacokinetics in the mammal host and pharmacodynamics in Anopheles gambiae.细胞色素 P450/ABC 转运体抑制同时增强了伊维菌素在哺乳动物宿主中的药代动力学和在冈比亚按蚊中的药效动力学。
Sci Rep. 2017 Aug 17;7(1):8535. doi: 10.1038/s41598-017-08906-x.
6
Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a Porcine Model.新型口服疥疮治疗药物莫昔克丁单剂量的临床前研究:在猪模型中与两剂量伊维菌素相比的疗效、安全性和药代动力学
PLoS Negl Trop Dis. 2016 Oct 12;10(10):e0005030. doi: 10.1371/journal.pntd.0005030. eCollection 2016 Oct.
7
Ivermectin-loaded lipid nanocapsules: toward the development of a new antiparasitic delivery system for veterinary applications.载伊维菌素脂质纳米囊:迈向用于兽医应用的新型抗寄生虫给药系统的开发。
Parasitol Res. 2016 May;115(5):1945-53. doi: 10.1007/s00436-016-4937-1. Epub 2016 Feb 6.
8
Screening for an ivermectin slow-release formulation suitable for malaria vector control.筛选适用于疟疾媒介控制的伊维菌素缓释制剂。
Malar J. 2015 Mar 5;14:102. doi: 10.1186/s12936-015-0618-2.
9
Ivermectin in senegalese peulh sheep: influence of sex on plasma disposition.伊维菌素在塞内加尔富拉尼绵羊中的应用:性别对血浆处置的影响。
Vet Res Commun. 2007 Aug;31(6):739-47. doi: 10.1007/s11259-007-3522-6. Epub 2007 Jan 27.
4
The pharmacokinetics of ivermectin after oral and subcutaneous administration to sheep and horses.伊维菌素对绵羊和马口服及皮下给药后的药代动力学。
J Vet Pharmacol Ther. 1987 Jun;10(2):175-9. doi: 10.1111/j.1365-2885.1987.tb00097.x.
5
The pharmacodynamics of ivermectin in sheep and cattle.伊维菌素在绵羊和牛体内的药效学。
J Vet Pharmacol Ther. 1988 Sep;11(3):260-8. doi: 10.1111/j.1365-2885.1988.tb00151.x.
6
CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates.CSTRIP,一个用于获取初始多指数参数估计值的Fortran IV计算机程序。
J Pharm Sci. 1976 Jul;65(7):1006-10. doi: 10.1002/jps.2600650713.